Stomach News and Research

RSS

Stomach flu vaccine possibility

Every year, millions of people are infected with noroviruses - commonly called "stomach flu" - often resulting in up to 72 hours of vomiting and diarrhea.

14 Feb 2008

Respiration device for detecting early-stage respiratory irregularities in premature babies

A start-up company is developing a novel, non-invasive device for detecting early-stage respiratory irregularities in premature babies, children and adults receiving ICU care.

8 Feb 2008

Merck to pay over $650 million for fraudulent price reporting and kickbacks claims

Merck & Company has agreed to pay more than $650 million to resolve allegations that the pharmaceutical manufacturer failed to pay proper rebates to Medicaid and other government health care programs and paid illegal remuneration to health care providers to induce them to prescribe the company's products, the Justice Department has announced.

8 Feb 2008

Fats encapsulated with fiber may lead to tasty low-calorie foods

Low-fat foods are often disappointing to consumers since removing the fat changes the desirable taste, texture and aroma of the original product.

8 Feb 2008

Beetroot juice reduces blood pressure

Researchers at Barts and The London School of Medicine have discovered that drinking just 500ml of beetroot juice a day can significantly reduce blood pressure.

7 Feb 2008

Ascal (calcium carbasalate) not safer than aspirin

Changing prescription of low-dose aspirin into calcium carbasalate (brand name: Ascal) to prevent peptic ulcerations is not useful. Peptic ulcers are evenly distributed among users of calcium carbasalate and aspirin, for secondary prevention of myocardial infarction.

5 Feb 2008

FDA approves only once-daily inhaled corticosteroid for children

Schering-Plough Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved ASMANEX TWISTHALER 110 mcg (mometasone furoate inhalation powder) for the maintenance treatment of asthma as a preventive therapy in patients 4 to 11 years of age.

4 Feb 2008

Hawthorn extract helps the heart

Taking hawthorn extract can help control symptoms of chronic heart disease such as low abilities to work and walk, and also improve a range of heart-related measurements.

24 Jan 2008

$Bisphosphate drug alendronate can help prevent bone fractures in many postmenopausal women$

Bisphosphate drug alendronate can help prevent bone fractures in many postmenopausal women

Giving 10mg per day of the bisphosphate drug alendronate to women after their menopause can help prevent loss of bone mass, reducing their risk of fractures, a Cochrane Review has found.

24 Jan 2008

Molecules might identify high-risk acute-leukemia patients

New research suggests that certain small molecules used by cells to control the proteins they make might also help doctors identify adult acute-leukemia patients who are likely to respond poorly to therapy.

16 Jan 2008

Gender differences in liver cancer

A fundamental difference in the way males and females respond to chronic liver disease at the genetic level helps explain why men are more prone to liver cancer, according to MIT researchers.

16 Jan 2008

Kiss but don't shake hands to stay healthy!

Scientists from the London School of Hygiene say a quick "air kiss" on the cheek is a relatively-germ free affair when compared to a hand-shake.

16 Jan 2008

Overweight people may not know when they've had enough

Researchers at the U.S. Department of Energy's Brookhaven National Laboratory have found new clues to why some people overeat and gain weight while others don't.

10 Jan 2008

Experts say far too much is spent on needless indigestion drugs

According to two experts in Britain the National Health Service (NHS) is needlessly spending at least 100m pounds per year on indigestion drugs.

7 Jan 2008

Hopkins researchers paint picture of cancer-promoting culprit

They say that a picture can be worth a thousand words. This especially is true for describing the structures of molecules that function to promote cancer.

7 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008